ZenaTech Letter to Shareholders Outlines 316% Q2 Revenue Growth and Seventh Consecutive Quarter of Sequential Growth
October 1, 2026
Host Jon Najarian interviews Executive Chairman and Director, Jeff Thramann. He provides information about Spectroscopy, a new way to identify pain for the treatment & surgery on patients